Navigation Links
Schering-Plough Addresses Major Milestones and Challenges in,Treatment of Patients With Chronic Hepatitis C

es with PEGINTRON will be presented at EASL evaluating patient response to therapy at certain treatment milestones, an approach that is aimed at individualising treatment for patients.

Schering-Plough also is exploring novel therapeutic approaches with PEGINTRON in combination with investigational antiviral agents to optimize treatment for patients with more difficult-to-treat forms of the disease, such as those with HCV genotype 1 and nonresponders to previous therapy.

Schering-Plough is undertaking a large, fully integrated clinical development program for its oral HCV protease inhibitor boceprevir (SCH 503034), with the goal of developing new strategies for improving treatment outcomes for patients with hepatitis C.

As part of this effort, Schering-Plough has collaborated with Wyeth/ViroPharma and Idenix/Novartis to conduct separate in vitro studies of boceprevir in combination with their respective investigational HCV polymerase inhibitors, HCV-796, a non-nucleoside polymerase inhibitor, and NM107 (the active moiety of NM283, valopicitabine), a nucleoside polymerase inhibitor. These in vitro experiments suggest that the combination of boceprevir and either one of these polymerase inhibitors achieves additive antiviral activity and a complementary resistance profile; the combination of two agents increases the barrier for developing resistance to either drug alone.

In addition, Schering-Plough has initiated the HCV SPRINT-1 study (HCV Serine Protease Inhibitor Therapy-1), a large Phase II study that is currently enrolling 400 HCV genotype 1, treatment-naïve patients in sites across the United States, Canada and Europe. The primary objective of the study is to evaluate the safety and efficacy of boceprevir 800 mg TID in combination with PEGINTRON and REBETOL in the treatment-naïve patient population.

Schering-Plough also is conducting a large Phase II study evaluating the safety and efficacy of boceprevi
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Announces Hepatitis C Data Presentations at Digestive Disease Week (DDW) 2007 Annual Meeting
2. Schering-Plough Announces Presentation of Phase II Trial Results for Novel Oral Thrombin Receptor Antagonist at the 2007 Annual Meeting of The American College of Cardiology/i2 Summit
3. New Position Statement from The North American Menopause Society Addresses Use of Local Estrogen for Treatment of Vaginal Atrophy in Postmenopausal Women
4. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
5. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
6. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
7. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
8. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
9. Major Manufacturer of Unapproved and Adulterated Drugs
10. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
11. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
Post Your Comments:
(Date:8/29/2014)... 2014  In part four of a ... pharmacy as a strategic asset, Mary Baxter, MBA, ... Cardinal Health,s Innovation Delivery Solutions business, discusses how expanding ... hospitals and patients. "Every hospital pharmacist knows ... their job in a value-based healthcare world," Baxter says. ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Global Orthopedic Soft Tissue Repair Devices Market 2014-2018" ... tissues are the mass of cells that connect, support, ... soft tissues such as tendons, ligaments, cartilage, fascia, and ... degeneration of these tissues with age result in wear ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Services Industry (U.S.): Analytics, Extensive Financial ... 2021, NAIC 541380 ... Testing Laboratories, Safety and Compliance Services ...
Breaking Medicine Technology:Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 2Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 3Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 4Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 5Testing Laboratories, Safety and Compliance Services Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 541380 6
... /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX ) ... developing, manufacturing and marketing biopharmaceutical products, today announced that ... Tan, chief financial officer, will present at the Oppenheimer ... March 14-15, 2012 in New York City. ...
... 6, 2012  In a joint announcement today, the University of ... ERT ), report the launch of the ... patients suffering from Chronic Obstructive Pulmonary Disease (COPD).  COPD ... to the World Health Organization, will become the world,s ...
Cached Medicine Technology:ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 2ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 3ERT and UCLA Initiate Innovative Pilot Program for Chronically Ill Patients 4
(Date:8/29/2014)... 29, 2014 TayganPoint Consulting Group, a ... the second time, Inc. Magazine has named the company ... , Based on solid revenue growth of over 166% ... overall on the list. TayganPoint’s repeat success in ... the past few years, is a demonstration of its ...
(Date:8/29/2014)... Innovations Television, produced by DMG Productions, announced ... Innovations, focusing on health and elderly care, slated to air ... of Americans over 65 will nearly double by 2030, expanding ... 2030, for a total of 72 million people. Though many ... at least one chronic condition and use healthcare services more ...
(Date:8/29/2014)... CA (PRWEB) August 29, 2014 Fat is ... and bad fat. Brown fat is usually stored in the ... white fat typically reveals itself in overflowing bellies, muffin tops, ... fats occur naturally in many foods and promote better health, ... risks, including elevated bad cholesterol levels and lower good cholesterol ...
(Date:8/29/2014)... Scientists from four European countries say ... correlates with overall survival of mesothelioma. Surviving Mesothelioma has ... Click here to read it now. , Doctors ... cases of 523 mesothelioma patients who were ... [progression-free survival at 18 weeks after treatment] was strongly ...
(Date:8/29/2014)... Botanica Day Spa recently announced the ... menu along with a special introductory offer for the ... uses small glass cups to create a suctioning of ... a comfortable but effective pressure. The cups are then ... engage more tissue. In contrast, traditional massage primarily uses ...
Breaking Medicine News(10 mins):Health News:Innovations with Ed Begley, Jr., Seeking Content for Upcoming Series on Health and Elder Care 2Health News:Diet Doc Announces Modernized, Interesting and Easy to Follow Diet Plans that Deliver Fast Weight Loss and Teach Patients the Difference Between Good and Bad Fat 2Health News:Diet Doc Announces Modernized, Interesting and Easy to Follow Diet Plans that Deliver Fast Weight Loss and Teach Patients the Difference Between Good and Bad Fat 3Health News:European Study Says Disease Progression Predicts Mesothelioma Survival Better Than Treatment Response, According to Surviving Mesothelioma 2Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 2Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 3Health News:Cupping Massage Now Available at Botanica Day Spa in Clearwater, FL 4
... of adverse events for diabetes drug , , THURSDAY, Oct. ... should be banned in the United States because it ... other life-threatening risks that greatly outweigh its benefits, the ... said it has identified 14 cases of Avandia-induced liver ...
... epidemic is fueling the type 2 disease epidemic, officials say ... new cases of type 2 diabetes has nearly doubled in ... cases appearing in southern states, federal officials reported Thursday. , ... 1,000 people from 1995 to 1997 to 9.1 per 1,000 ...
... Pet Owners and Contribute to Research, BREA, ... sentence,for pets, cancer is claiming fewer four-legged victims ... of pet owners to pursue those,treatments. Veterinary Pet ... insurer, will seek to raise national awareness about ...
... Connextions Offers Best Practices and Lessons Learned from Other Industries, ... ... (PRWEB) October 30, 2008 -- Companies who have watched their ... or "Chat," are increasingly considering this technology for their own ...
... (Oct. 30, 2008) -- Weill Cornell Medical College announced ... Explorations grants from the Bill & Melinda Gates Foundation. ... "Untimely Triggering of the Fusion Mechanism Used by Viruses ... conducted by Dr. Anne Moscona, and "Senescent and Rejuvenated ...
... Interview Her Virtually at http://www.bodybymilk.com , WASHINGTON, ... graduating from high school, becoming a Billboard,chart-topping country super ... the Year, Swift has a hectic schedule. She knows ... she needs to stay in top shape. That,s,why she ...
Cached Medicine News:Health News:Consumer Group Seeks FDA Ban on Avandia 2Health News:Consumer Group Seeks FDA Ban on Avandia 3Health News:Rate of Diabetes Cases Doubles in 10 Years: CDC 2Health News:Rate of Diabetes Cases Doubles in 10 Years: CDC 3Health News:Veterinary Pet Insurance Kicks Off Fourth Annual Pet Cancer Awareness Month 2Health News:Veterinary Pet Insurance Kicks Off Fourth Annual Pet Cancer Awareness Month 3Health News:Companies Turn to Click-to-Chat Technology to Reduce Operating Expense and Enhance Customer Service 2Health News:Companies Turn to Click-to-Chat Technology to Reduce Operating Expense and Enhance Customer Service 3Health News:Companies Turn to Click-to-Chat Technology to Reduce Operating Expense and Enhance Customer Service 4Health News:Weill Cornell Medical College receives 2 $100,000 grants for innovative global health research 2Health News:Country Super Star Taylor Swift Stays Fearless With a Little Help From Milk 2
... Euclid Systems Orthokeratology (oprifocon A) Contact ... lenses used for orthokeratology, a process ... patient wears these lenses overnight and ... the day, nearsightedness is temporarily corrected ...
... rigid gas permeable contact lenses used for ... corrects nearsightedness (myopia). The patient wears the ... upon wakening. During the day, nearsightedness is ... and Quadra RG contact lenses apply slight ...
MDI will work with your facility to determine the best interim lab to fit your needs and your site....
... same as the model SP-8800 with one big exception. ... This mode has its own fixation targets to allow ... allows you to select an area on the cornea ... to calculate averages of multiple readings in any one ...
Medicine Products: